Dazopride
From Self-sufficiency
Jump to: navigation, search
File:Dazopride.png | |
Systematic (IUPAC) name | |
---|---|
4-amino-5-chloro-N-(1,2-diethylpyrazolidin-4-yl)-2-methoxy-benzamide | |
Clinical data | |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 70181-03-2 |
ATC code | none |
PubChem | CID 54801 |
ChemSpider | 49487 |
Chemical data | |
Formula | C15H23ClN4O2 |
Molar mass | 326.82 g/mol[[Script error: No such module "String".]] |
Dazopride (AHR-5531) is an antiemetic and gastroprokinetic agent of the benzamide class which was never marketed.[1][2][3][4][5] It acts as a 5-HT3 receptor antagonist and 5-HT4 receptor agonist.[3][4][6] In addition to its gastrointestinal effects, dazopride facilitates learning and memory in mice.[7]
See also
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
5-HT3 Antagonists | Alosetron • Azasetron • Bemesetron • Cilansetron • Clozapine • Dazopride • Dolasetron • Granisetron • Lerisetron • Metoclopramide • Mianserin • Mirtazapine • Olanzapine • Ondansetron • Palonosetron • Ramosetron • Ricasetron • Tropisetron • Zatosetron | ||
---|---|---|---|
CB1 Agonists (Cannabinoids) | |||
D2/D3 Antagonists | |||
H1 Antagonists (Antihistamines) | |||
mACh Antagonists (Anticholinergics) | |||
NK1 Antagonists | |||
Others | |||
Drugs for functional gastrointestinal disorders (A03) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drugs for functional bowel disorders |
| ||||||||||||
Belladonna and derivatives (antimuscarinics) | tertiary amines: Atropine · Hyoscyamine quaternary ammonium compounds: Scopolamine (Butylscopolamine, Methylscopolamine) · Methylatropine · Fentonium · Cimetropium bromide | ||||||||||||
Propulsives | |||||||||||||
45px | This drug article relating to the gastrointestinal system is a stub. You can help ssf by expanding it. |
- ↑ Grant SC, Kris MG, Gralla RJ, Clark RA, Tyson LB (1993). "Dose-ranging evaluation of the substituted benzamide dazopride when used as an antiemetic in patients receiving anticancer chemotherapy". Cancer Chemotherapy and Pharmacology. 31 (6): 442–4. PMID 8453682. CS1 maint: Multiple names: authors list (link)
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
- ↑ 3.0 3.1 Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
- ↑ 4.0 4.1 Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
- ↑ David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
- ↑ Montgomery, S. A.; Halbreich, Uriel (2000). Pharmacotherapy for mood, anxiety, and cognitive disorders. Washington, DC: American Psychiatric Press. ISBN 0-88048-885-9. CS1 maint: Multiple names: authors list (link)
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=Dazopride&oldid=23884"
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- 2Fix
- Serotonin receptor agonists
- 5-HT3 antagonists
- Antiemetics
- Benzamides
- Phenol ethers
- Aromatic amines
- Organochlorides
- Pyrazolidines
- Gastrointestinal system drug stubs
- CS1 maint: Multiple names: authors list